Lori Hu

Lori Hu is a highly accomplished professional with a strong educational background and extensive experience in the fields of business, international studies, and biomedical engineering.

She holds a Master of Business Administration (M.B.A.) from The Wharton School, a Master's Degree in International Studies from The Lauder Institute at the University of Pennsylvania, and a Bachelor of Science in Biomedical Engineering from Duke University.

Throughout her career, Lori has held significant positions in various organizations, showcasing her expertise and leadership capabilities.

Her notable roles include being a Board Observer at TORL BioTherapeutics, LLC, a Board Director at SonoThera, Indapta Therapeutics, Neuspera Medical Inc., Palleon Pharmaceuticals, and Elevation Oncology.

Lori has also served as a Managing Director at Vertex Ventures HC, contributing her strategic insights to the healthcare sector.

Her diverse experience includes being a Board Director at BlackThorn Therapeutics, Board Observer at Ivantis, Inc., VC Associate at S.R. One Ltd, and Associate Director of Business Development at Bristol-Myers Squibb.

Prior to these roles, she gained valuable experience as a Management Consultant at Accenture, where she refined her analytical and problem-solving skills.

Lori Hu's background reflects her dedication to contributing valuable insights and making strategic decisions across various industries.

Her academic achievements and professional experiences have equipped her with a unique skill set that combines business acumen, technical knowledge, and an understanding of international dynamics.

Lori Hu continues to be a prominent figure in the business and healthcare sectors, bringing a wealth of expertise and a track record of success to every organization she is involved with.